butamidine has been researched along with primaquine in 1 studies
| Studies (butamidine) | Trials (butamidine) | Recent Studies (post-2010) (butamidine) | Studies (primaquine) | Trials (primaquine) | Recent Studies (post-2010) (primaquine) |
|---|---|---|---|---|---|
| 9 | 0 | 2 | 2,196 | 196 | 711 |
| Protein | Taxonomy | butamidine (IC50) | primaquine (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.1824 | |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 7.5 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.016 | |
| Serine hydroxymethyltransferase, mitochondrial | Homo sapiens (human) | 0.4365 | |
| Thiosulfate sulfurtransferase | Homo sapiens (human) | 2.9 | |
| 60 kDa chaperonin | Escherichia coli | 6.2 | |
| 10 kDa chaperonin | Escherichia coli | 6.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Queener, SF | 1 |
1 review(s) available for butamidine and primaquine
| Article | Year |
|---|---|
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.
Topics: Animals; Drug Design; Humans; Immunosuppression Therapy; Molecular Structure; Opportunistic Infections; Pneumonia, Pneumocystis; Structure-Activity Relationship | 1995 |